Edshann
you keep changing the discussion.
you have been banging on about CY targets , meeting vs exceeding target and when I point out they only need 134k production this half to EXCEED prod target you start l talking about end of 22 prod and whether they extend Boonanaring. By sept next year cash even after divi of 12% will be 110 m plus so who cares if they have a quarter of lower revenue at the end of 22
you are caught up in irrelevant detail such meeting or exceeding CY targets you miss the bigger picture
would you by Atlas and Biddimina for an EV of 80m
whether they have 90m or 120 when they move to atlas i see as largely irrelevant
on the production front they only need to average 67k per quarter to reach upper end of prod guidance . When I recently asked the company about beating guidance the answer was it’s certainly possibility
- Forums
- ASX - By Stock
- IMA
- Ann: Half Year Accounts
Ann: Half Year Accounts, page-40
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMA (ASX) to my watchlist
|
|||||
Last
7.4¢ |
Change
-0.001(0.68%) |
Mkt cap ! $82.54M |
Open | High | Low | Value | Volume |
7.4¢ | 7.4¢ | 7.4¢ | $15.79K | 213.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 156173 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 21003 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 156173 | 0.073 |
4 | 74000 | 0.072 |
1 | 55000 | 0.071 |
3 | 171220 | 0.070 |
1 | 10000 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 21003 | 1 |
0.075 | 20000 | 1 |
0.078 | 49297 | 1 |
0.079 | 55889 | 2 |
0.080 | 35495 | 1 |
Last trade - 15.56pm 15/07/2024 (20 minute delay) ? |
Featured News
IMA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online